Chen, Yucherng http://orcid.org/0000-0002-2755-0147
Noma, Satoshi
Taguchi, Yoshio
Takahashi, Masashi
Tsurutani, Junji
Mori, Shiho
Sakaguchi, Sachi
Asou, Hiroya
Tomii, Keisuke
Funding for this research was provided by:
Eli Lilly Japan K.K
Article History
Received: 12 August 2020
Accepted: 20 December 2020
First Online: 16 January 2021
Compliance with ethical standards
:
: Masashi Takahashi, Junji Tsurutani, Yoshio Taguchi,, Keisuke Tomii, and Satoshi Noma were members of the ILDAC and report personal fees from Eli Lilly Japan K.K. during the conduct of the study.Junji Tsurutani also reports non-financial support from Articulate Science LLC during the conduct of the study; and research grants or donations to his institute from Daiichi Sankyo, Kyowa Hakko Kirin, Chugai, Eli Lilly Japan K.K., Eisai, MSD, Pfizer, and Japan Society of Clinical Oncology; personal fees from Daiichi Sankyo, Kyowa Hakko Kirin, Chugai, Eisai, MSD, Pfizer, Taiho, Novartis, Nihon Kayaku, and Aasahi Kasei; and an advisory relationship with Daiichi-Sankyo, Eli Lilly Japan K.K., Eisai, MSD, and Aasahi Kasei outside the submitted work. Keisuke Tomii also reports personal fees from Boehringer Ingelheim and Shionogi outside the submitted work. Yucherng Chen, Shiho Mori, Sachi Sakaguchi, and Hiroya Asou are employees and minor stakeholders in Eli Lilly Japan K.K.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.